Eidelman Virant Capital P Lx Pharma Inc. Transaction History

Eidelman Virant Capital

  • $136 Million
  • Q3 2022

A detailed history of Eidelman Virant Capital transactions in P Lx Pharma Inc. stock. As of the latest transaction made, Eidelman Virant Capital holds 27,000 shares of PLXP stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,000
Previous 27,000 -0.0%
Holding current value
$0
Previous $63,000 73.02%
% of portfolio
0.01%
Previous 0.05%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022
BUY
$7.69 - $19.66 $73,055 - $186,770
9,500 Added 54.29%
27,000 $219,000
Q2 2021

Jul 19, 2021
BUY
$9.0 - $15.94 $157,500 - $278,950
17,500 New
17,500 $236,000

Others Institutions Holding PLXP

# of Institutions
4
Shares Held
61.6K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Eidelman Virant Capital Portfolio

Follow Eidelman Virant Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eidelman Virant Capital, based on Form 13F filings with the SEC.

News

Stay updated on Eidelman Virant Capital with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email